Sign in

CIK 0001412486 · Non-accelerated filer<br>Smaller reporting company

Cocrystal Pharma, Inc.

Sign in to watch
Ticker
COCP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
352528215
Phone
(786) 459-1831
Business address
19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
Former names
BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
  1. 4 Grant or award Director acquired 420,737 shares (grant or award)
  2. 4 Grant or award Director acquired 105,263 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Option exercise Director acquired 1,706,978 shares (option exercise)
  5. 4 Grant or award Director acquired 4,166,667 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale PRESIDENT sold 2,200,000 shares at $0.44 ($968,000)
  8. 4 Open-market buy Director bought 10,000 shares at $0.41 ($4,100)
  9. 4 Open-market buy Director bought 4,878,050 shares at $0.41 ($2,000,001)
  10. 4 Open-market buy INTERIM CEO bought 10,000 shares at $0.41 ($4,100)
  11. 4/A Open-market buy Director bought 39,216 shares at $0.51 ($20,000)
  12. 4 Open-market buy Director bought 2,941,177 shares at $0.51 ($1,500,000)
  13. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 294,118 shares at $0.51 ($150,000)
  14. 4 Open-market buy Director bought 50,000 shares at $0.51 ($25,500)
  15. 4 Open-market buy Director bought 49,020 shares at $0.51 ($25,000)
  16. 4 Open-market buy Director bought 39,216 shares at $0.51 ($20,000)
  17. 4 Open-market buy Director bought 2,941,176 shares at $0.51 ($1,500,000)
  18. 4 Open-market buy Director bought 1,235,294 shares at $0.51 ($630,000)
  19. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 100,000 shares at $0.58 ($57,870)
  20. 4 Derivatives Options or other derivatives

Page 5 of 8 · 141 filings